Idalopirdine Completed Phase 2 Trials for Alzheimer's Disease (AD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01019421Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease